Metraipolis › archive › dc_576fd646e71a
Incidence and risk factors of venous and arterial thromboembolism events in lung cancer patients treated with immune checkpoint inhibitors — Europe PMC PMID:42244874
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/42244874
- DOI
- 10.3389/fphar.2026.1608497
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-01T13:34:42.335Z
- SHA-256 of the archived text
d683459ebc54648b4ddc29998e5f71aaba3e71769ed00df74547015ff744017b- Stable URL of this page
https://metraipolis.com/documento/dc_576fd646e71a
How to cite
Incidence and risk factors of venous and arterial thromboembolism events in lung cancer patients treated with immune checkpoint inhibitors — Europe PMC PMID:42244874 — Europe PMC (en), https://europepmc.org/article/MED/42244874 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_576fd646e71a (Metraipolis archive dc_576fd646e71a, sha256 d683459ebc54648b4ddc29998e5f71aaba3e71769ed00df74547015ff744017b)
BibTeX
@misc{dc576fd646e71a,
title = {Incidence and risk factors of venous and arterial thromboembolism events in lung cancer patients treated with immune checkpoint inhibitors — Europe PMC PMID:42244874},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/42244874},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_576fd646e71a; sha256 d683459ebc54648b4ddc29998e5f71aaba3e71769ed00df74547015ff744017b},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42244874. Agents can read the archived copy with the MCP tool read_document.